Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

Lova Sun¹, Jeremy L Warner^{2

3}, Ravi B Parikh^{1

4}

Affiliations

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.
³ Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.
⁴ Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

Comment

Lova Sun et al. JAMA Oncol. 2021.

. 2021 Aug 1;7(8):1123-1125.

doi: 10.1001/jamaoncol.2021.2096.

Lova Sun¹, Jeremy L Warner^{2

3}, Ravi B Parikh^{1

4}

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.
³ Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.
⁴ Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

No abstract available

Comment on

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S, Yoshida T, Kojima Y, Yagishita S, Nakahama H, Okinaka K, Matsushita H, Shiotsuka M, Kobayashi O, Iwata S, Narita Y, Ohba A, Takahashi M, Iwasa S, Kobayashi K, Ohe Y, Yoshida T, Hamada A, Doi T, Yamamoto N. Yazaki S, et al. JAMA Oncol. 2021 Aug 1;7(8):1141-1148. doi: 10.1001/jamaoncol.2021.2159. JAMA Oncol. 2021. PMID: 34047762 Free PMC article.
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
Massarweh A, Eliakim-Raz N, Stemmer A, Levy-Barda A, Yust-Katz S, Zer A, Benouaich-Amiel A, Ben-Zvi H, Moskovits N, Brenner B, Bishara J, Yahav D, Tadmor B, Zaks T, Stemmer SM. Massarweh A, et al. JAMA Oncol. 2021 Aug 1;7(8):1133-1140. doi: 10.1001/jamaoncol.2021.2155. JAMA Oncol. 2021. PMID: 34047765 Free PMC article.